Others have shown that in rats whether BBB dysfunction was due to experimental stroke or TBI, a neutralizing monoclonal antibody (mAb) to HMGB1 prevented the BBB dysfunction [126, 127]. The gene discussed is HMGB1; the disease is stroke disorder.